• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Q-MED AB SOLESTA; AGENT, BULKING, INJECTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Q-MED AB SOLESTA; AGENT, BULKING, INJECTABLE Back to Search Results
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Cellulitis (1768); Fever (1858); Urinary Retention (2119); Discomfort (2330); Dysuria (2684)
Event Date 01/12/2015
Event Type  Injury  
Event Description
A medical assistant reported that a (b)(6) year old male received solesta (dextranomer/hyaluronic acid) injection into the submucosa of the anal canal as treatment for fecal incontinence.Additional medical history and concurrent medications were not provided.On (b)(6) 2015, the patient received solesta.Prophylactic antibiotics were not administered prior to implantation.On that same date, the patient experienced a fever and "not urinating as well".The patient was evaluated by his physician on (b)(6) 2014 and treatment began with acetaminophen/oxycodone and amoxicillin clavulanate.The patient was again seen by his physician on (b)(6) 2015 with complaints of rectal discomfort.On (b)(6) 2015, the patient was hospitalized for cellulitis in the rectal and urinary retention.While hospitalized, the patient received intravenous antibiotics and a foley catheter was inserted to treat the urinary retention.On (b)(6) 2015, the patient was discharged.The events were considered completely resolved on an unspecified date.The reporter felt the events were possibly related to the use of solesta.The company assessed the events as possibly related to solesta.
 
Manufacturer Narrative
A causal relation between the events and the treatment cannot be excluded.Although we do not understand why the patient developed urinary retention.Did the patient have a predisposition, e.G.Prostatic hypertrophy? lot number has not been reported and trending on batch cannot be performed.The case has been assessed as serious and fulfills criteria for reporting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SOLESTA
Type of Device
AGENT, BULKING, INJECTABLE
Manufacturer (Section D)
Q-MED AB
uppsala
SW 
Manufacturer Contact
8510 colonnade center dr
raleigh, NC 27615
9198621000
MDR Report Key4553855
MDR Text Key16307254
Report Number3009325614-2015-00011
Device Sequence Number1
Product Code LNM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Source Type Health Professional
Reporter Occupation Medical Assistant
Type of Report Initial
Report Date 02/25/2015,02/06/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA02/25/2015
Distributor Facility Aware Date02/06/2015
Date Report to Manufacturer02/25/2015
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/25/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age78 YR
-
-